Healthtech Startups
16,478 companies tagged Healthtech, with their investors and founders.
Pison manufactures a wearable neural watch that measures cognitive and physiological performance by reading signals between the brain and muscles. The device provides real-time analytics and training for mental readiness, agility, and focus, targeting individuals seeking performance optimization.
4 investors
Plum provides employee health insurance and healthcare for companies and their staff in India, aiming to make insurance more transparent and trustworthy. It offers group health insurance products through a technology-driven platform.
4 investors
PlushCare is a telehealth service that connects patients with board-certified primary care doctors and therapists through an app for virtual appointments, prescriptions, and ongoing care. It covers weight management, urgent care, pediatric care, chronic disease treatment, online therapy, and prescription discounts, serving patients across all 50 U.S. states.
4 investors
PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function. The company focuses on treating cancers driven by p53 mutations.
4 investors
Anthropic is an AI company that develops large language models, including its Claude models used by developers. The company reported a revenue run-rate growing from $1B to $9B during 2025 and later crossing $30B–$40B in annualized revenue.
4 investors
Portea Medical provides medical care in patients' homes, offering primary, preventive, and elderly care services. It focuses on making primary healthcare more accessible and affordable for patients.
4 investors
4 investors
4 investors
4 investors
Prenuvo operates whole-body MRI scanning clinics for early detection of cancer and diseases, offering fast, safe, non-invasive screening. The company serves health-conscious consumers seeking preventative health screening across North America.
4 investors
Prescryptive provides a digital healthcare platform that enables patients to view prescription prices in real-time, manage medications, and track healthcare spending. The platform serves patients, employers, pharmacies, pharmaceutical manufacturers, and health systems across the prescription and medication management process.
4 investors
Progyny provides employer-sponsored women's health and family-building benefits, covering preconception, fertility, pregnancy and postpartum, and menopause/midlife care through concierge support, digital tools, and a managed network of specialists. It serves organizations looking to offer these benefits to their workforce across the United States.
4 investors
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.
4 investors
Promakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis. The company targets patients with inflammatory diseases who do not benefit from current immunosuppressive treatments.
4 investors
Proteus Motion offers a patented assessment and 3D resistance training platform that measures full-body power, strength, and speed and generates personalized training and rehabilitation recommendations. It targets movement health and athletic performance applications.
4 investors
Proton Intelligence develops CKM™, a continuous monitoring medical device drawing on biosensing and minimally invasive microdevice technology for clinical use. The company operates in the medical device and diagnostics (IVD/point-of-care) space within health technology.
4 investors
Public Goods sells household, personal care, and everyday consumer products made with natural ingredients and sustainable materials, offered through a membership model. It also supplies products to businesses such as hospitality properties for guest amenities.
4 investors
Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery. The company operates in the medical device industry, serving pulmonologists and patients with severe emphysema through a minimally invasive lung treatment.
4 investors
Punto Health builds digital tools for cognitive care, connecting patients, carers, and clinicians to provide continuous, personalised support and coordinated care. It serves families and healthcare professionals managing age-related and cognitive conditions.
4 investors
PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings. The company targets healthcare providers and patients who use catheters.
4 investors
Qkine manufactures and supplies high-purity growth factors and cytokines for research and therapeutic applications, serving life sciences researchers and cell therapy developers. The company combines computational and experimental capabilities to produce complex protein-based tools for structural analysis and cell culture research.
4 investors
Qritive develops AI-powered modules and a digital pathology workbench (Pantheon) that help pathologists identify, grade, and classify cancer, including prostate and colon cancer, lymph node metastasis, and biomarker analysis. Its hardware-agnostic tools integrate into existing digital pathology workflows and image management systems for laboratories and healthcare providers.
4 investors
Qualio provides a compliance platform for life science companies that combines quality management, regulatory intelligence, and AI agents to accelerate product delivery. The platform helps organizations optimize their quality and compliance systems.
4 investors
Quilt Health builds infrastructure to connect care delivery and medical discovery for patients with complex conditions, enabling coordinated access to both ongoing clinical care and innovative therapies. The platform addresses fragmented data systems that impede safe care coordination and clinical trial enrollment across disparate healthcare providers.
4 investors